Skip to main content
Equibles
NPCE logo

NPCE · NeuroPace Inc · Investor Relations

Track NPCE — free

Use NPCE with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research NPCE.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$14.59 +0.55 (+3.92%)
Russell 2000 member Rebalance outlook locked
Market Cap
$481.91M
Shares
34.32M

Press releases and events scraped from the company's investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.

Recent news

Date Headline
2026-09-01 NeuroPace to Participate in 2026 Cantor Global Healthcare Conference
2026-08-31 NeuroPace to Participate in Wells Fargo 21st Annual Healthcare Conference
2026-08-11 NeuroPace Reports Second Quarter 2026 Financial Results and Raises 2026 Revenue Guidance
2026-07-28 NeuroPace Receives FDA Guidance on PMA Supplement for Indication Expansion into Idiopathic Generalized Epilepsy
2026-05-29 NeuroPace to Highlight Expanding Role of Responsive Neuromodulation at the 2026 American Society for Stereotactic and Functional Neurosurgery (ASSFN) Meeting
2026-05-29 NeuroPace Announces FDA Approval of ECoG Assistant™, Advancing AI-Driven Epilepsy Care
2026-05-12 NeuroPace Reports First Quarter 2026 Financial Results and Raises 2026 Revenue Guidance
2026-04-29 NeuroPace to Report First Quarter 2026 Financial Results on May 12, 2026
2026-04-27 NeuroPace Highlights Expanding Clinical Evidence Leadership with Published 3-Year Post-Approval Study (PAS) Results in Neurology and NAUTILUS Presentation at AAN 2026
2026-04-10 NeuroPace to Present at the 25th Annual Needham Virtual Healthcare Conference
2026-03-05 NeuroPace to Present at the Leerink Global Healthcare Conference
2026-03-03 NeuroPace Reports Fourth Quarter and Full Year 2025 Financial Results and Reiterates 2026 Outlook
2026-02-20 NeuroPace to Report Fourth Quarter 2025 Financial Results on March 3, 2026
2026-01-13 NeuroPace Reports Preliminary Unaudited Results for the Fourth Quarter and Fiscal Year 2025 and Initial 2026 Outlook

Past events

Date Event Type
2026-09-09 2026 Cantor Global Healthcare Conference Conference
2026-09-08 Wells Fargo 21st Annual Healthcare Conference Conference
2026-08-11 Earnings conference call (announced in 8-K) Earnings call
2026-07-28 IGE PMA Supplement Update Call Event
2026-05-12 Q1 2026 NeuroPace Earnings Conference Call Earnings call
2026-04-14 25th Annual Needham Virtual Healthcare Conference Conference
2026-03-11 Leerink Global Healthcare Conference Conference
2026-03-03 Q4 2025 NeuroPace Earnings Conference Call Earnings call
2026-01-14 44th Annual JP Morgan Healthcare Conference Conference
2025-11-04 Q3 2025 NeuroPace Earnings Conference Call Earnings call
2025-09-04 Cantor Global Healthcare Conference Conference
2025-08-12 Q2 2025 NeuroPace Earnings Conference Call Earnings call
2025-05-27 NeuroPace Update Call: Preliminary Results from One-Year Data in NAUTILUS Study Earnings call
2025-05-13 Q1 2025 NeuroPace Earnings Conference Call Earnings call
2025-04-08 24th Annual Needham Virtual Healthcare Conference Conference
2025-03-10 Leerink Global Healthcare Conference Conference
2025-03-04 Q4 2024 NeuroPace Earnings Conference Call Earnings call
2025-01-28 NeuroPace In-Person Investor Day Presentation
2025-01-16 43rd Annual JP Morgan Healthcare Conference Conference
2024-11-12 Q3 2024 NeuroPace Earnings Conference Call Earnings call

Source: https://investors.neuropace.com/overview/default.aspx

Key facts CIK 1528287 CUSIP 641288105 13F (30d) 2 filings 2 filers Visit website Investor relations